In another study, the increased expression of SCD in T98G and U87 MG glioma cells correlated with higher temozolomide (TMZ)-resistance, which contributed to the reduced survival of patients after TMZ-based chemotherapy [63]. The gene discussed is SCD; the disease is central nervous system cancer.